Statistics
Publications
3
Citations
46
H-Index
3
Active since
2022
Jianping Kong is an author at China Pharmaceutical University specializing in cancer nanomedicine, liposome drug release, and chemotherapy.
Publications per year
2022–2024
3
3
Antiviral signaling of a type III CRISPR-associated deaminase
Zhaoxing Li, P. S. Yan, Chenyang Hua et al. · Science · 2024 · 14 citations
1–3 of 3